These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 15270900)

  • 1. Immunohistochemical analyses of p63 expression in normal human skin.
    Takeuchi Y; Tamura A; Kamiya M; Suzuki K; Ishikawa O
    Br J Dermatol; 2004 Jul; 151(1):232-5. PubMed ID: 15270900
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunohistochemical analyses of p63 expression in cutaneous tumours.
    Takeuchi Y; Tamura A; Kamiya M; Fukuda T; Ishikawa O
    Br J Dermatol; 2005 Dec; 153(6):1230-2. PubMed ID: 16307669
    [No Abstract]   [Full Text] [Related]  

  • 3. p63 expression in odontogenic cysts.
    Lo Muzio L; Santarelli A; Caltabiano R; Rubini C; Pieramici T; Fior A; Trevisiol L; Carinci F; Leonardi R; Bufo P; Lanzafame S; Piattelli A
    Int J Oral Maxillofac Surg; 2005 Sep; 34(6):668-73. PubMed ID: 16053892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of p63 protein and mRNA in oral epithelial dysplasia.
    Chen YK; Hsue SS; Lin LM
    J Oral Pathol Med; 2005 Apr; 34(4):232-9. PubMed ID: 15752259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [p504s-p63 mixed markers in the diagnosis of prostatic carcinoma].
    Zhang JK; Chen LL; Zhou XG
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(23):1647-8. PubMed ID: 16185538
    [No Abstract]   [Full Text] [Related]  

  • 6. Decreased expression of p63 in oral lichen planus and graft-vs.-host disease associated with oral inflammation.
    Ebrahimi M; Wahlin YB; Coates PJ; Sjöström B; Nylander K
    J Oral Pathol Med; 2006 Jan; 35(1):46-50. PubMed ID: 16393253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of basal cell cocktail (34betaE12 + p63) in the diagnosis of atypical prostate glandular proliferations.
    Shah RB; Kunju LP; Shen R; LeBlanc M; Zhou M; Rubin MA
    Am J Clin Pathol; 2004 Oct; 122(4):517-23. PubMed ID: 15487448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical expression of p16, p53, and p63 in colorectal adenomas and adenocarcinomas.
    Carneiro FP; Ramalho LN; Britto-Garcia S; Ribeiro-Silva A; Zucoloto S
    Dis Colon Rectum; 2006 May; 49(5):588-94. PubMed ID: 16575619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunodetection of GLUT1, p63 and phospho-histone H1 in invasive head and neck squamous carcinoma: correlation of immunohistochemical staining patterns with keratinization.
    Burstein DE; Nagi C; Kohtz DS; Lee L; Wang B
    Histopathology; 2006 May; 48(6):717-22. PubMed ID: 16681688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p63 and the epithelial stem cell: more than status quo?
    McKeon F
    Genes Dev; 2004 Mar; 18(5):465-9. PubMed ID: 15037544
    [No Abstract]   [Full Text] [Related]  

  • 11. A lack of prognostic significance regarding DeltaNp63 immunoreactivity in lung cancer.
    Iwata T; Uramoto H; Sugio K; Fujino Y; Oyama T; Nakata S; Ono K; Morita M; Yasumoto K
    Lung Cancer; 2005 Oct; 50(1):67-73. PubMed ID: 15950316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p63: oncogene or tumor suppressor?
    Mills AA
    Curr Opin Genet Dev; 2006 Feb; 16(1):38-44. PubMed ID: 16359856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p63 overexpression associates with poor prognosis in head and neck squamous cell carcinoma.
    Lo Muzio L; Santarelli A; Caltabiano R; Rubini C; Pieramici T; Trevisiol L; Carinci F; Leonardi R; De Lillo A; Lanzafame S; Bufo P; Piattelli A
    Hum Pathol; 2005 Feb; 36(2):187-94. PubMed ID: 15754296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of p63 and cytokeratin expression in a cultivated limbal autograft used in the treatment of limbal stem cell deficiency.
    Harkin DG; Barnard Z; Gillies P; Ainscough SL; Apel AJ
    Br J Ophthalmol; 2004 Sep; 88(9):1154-8. PubMed ID: 15317707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous p63 acts as a survival factor for tumour cells of SCCHN origin.
    Thurfjell N; Coates PJ; Vojtesek B; Benham-Motlagh P; Eisold M; Nylander K
    Int J Mol Med; 2005 Dec; 16(6):1065-70. PubMed ID: 16273287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies targeting p63 react specifically in the cytoplasm of breast epithelial cells exhibiting secretory differentiation.
    Bratthauer GL; Saenger JS; Strauss BL
    Histopathology; 2005 Dec; 47(6):611-6. PubMed ID: 16324199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of p63 and 14-3-3sigma in normal and hyperdifferentiated mucosa of the upper aerodigestive tract.
    Sniezek JC; Matheny KE; Burkey BB; Netterville JL; Pietenpol JA
    Otolaryngol Head Neck Surg; 2002 Jun; 126(6):598-601. PubMed ID: 12087324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virtual microscopy in prostate histopathology: simultaneous viewing of biopsies stained sequentially with hematoxylin and eosin, and alpha-methylacyl-coenzyme A racemase/p63 immunohistochemistry.
    Helin HO; Lundin ME; Laakso M; Lundin J; Helin HJ; Isola J
    J Urol; 2006 Feb; 175(2):495-9. PubMed ID: 16406979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of different p63 variants in healing skin wounds suggests a role of p63 in reepithelialization and muscle repair.
    Bamberger C; Hafner A; Schmale H; Werner S
    Wound Repair Regen; 2005; 13(1):41-50. PubMed ID: 15659035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential recognition of response elements determines target gene specificity for p53 and p63.
    Osada M; Park HL; Nagakawa Y; Yamashita K; Fomenkov A; Kim MS; Wu G; Nomoto S; Trink B; Sidransky D
    Mol Cell Biol; 2005 Jul; 25(14):6077-89. PubMed ID: 15988020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.